
    
      The long-term clinical benefit of tight glycemic control in people with diabetes is well
      known . HbA1c generally assesses the average/long term quality of glycemic control, it has
      been clearly demonstrated that a target of HbA1c at 7.0% or less has benefits for diabetic
      patients
    
  